JAMA Dermatology发表研究:硬皮病患者癌症风险升高
Morphea linked to higher risk for cancer
JAMA Dermatology于2026年11月11日在线发表的研究对加拿大行政医保数据库中6,181例硬皮病(morphea)患者和8,133例系统性硬化症(SSc)患者进行了回顾性队列分析,随访至2020年。
加拿大医保数据库队列结果显示硬皮病患者整体及实体瘤风险升高,为皮肤科随访策略提供参考。
Morphea is associated with excess cancer incidence, according to a study published online Nov. 11 in JAMA Dermatology.
Jessica Muha, from McGill University in Montreal, and colleagues examined whether patients with morphea have an increased risk of cancer compared to the general population and patients with systemic sclerosis (SSc). The analysis included 6,181 patients with morphea and 8,133 patients with SSc identified from Canadian administrative health databases (1996 to 2019 with follow-up through 2020).
The researchers found that during the study period, 12.65% of patients with morphea and 13.57% with SSc developed cancer, yielding an increased overall cancer incidence (morphea: standardized incidence ratio [SIR], 1.24; SSc: SIR, 1.37). In both cohorts, solid tumor risk was elevated (morphea SIR, 1.17; SSc SIR, 1.21). Hematologic cancer risk was only significantly elevated in patients with SSc (SIR, 2.40; 95% confidence interval [CI], 1.92 to 2.96) but not those with morphea (SIR, 1.34; 95% CI, 0.97 to 1.81).
In the morphea group, female reproductive and breast cancers predominated, while lung cancer was most frequent among patients with SSc. The highest relative risk was seen in younger patients. Immunosuppressant use was associated with lower cancer risk in both cohorts (morphea: hazard ratio [HR], 0.56; SSc: HR, 0.63).
"These findings suggest that morphea, like SSc, is associated with excess cancer incidence and merits oncologic attention, despite historically receiving little investigation," the authors write.
One author disclosed ties to the pharmaceutical industry.
Publication details
Jessica Muha et al., Incidence of Cancer in Morphea and Systemic Sclerosis, JAMA Dermatology (2026). DOI: 10.1001/jamadermatol.2026.4685
Journal information: JAMA Dermatology
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
© 2026 HealthDay. All rights reserved.
Citation: Morphea linked to higher risk for cancer (2026, November 18) retrieved 18 November 2026 from https://medicalxpress.com/news/2026-11-morphea-linked-higher-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com